Literature DB >> 7042757

Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.

M D Kazatchkine, D T Fearon, M D Appay, C Mandet, J Bariety.   

Abstract

The presence and distribution of C3b receptors in normal human kidneys and in biopsies from 75 patients with renal disease were investigated by immunohistochemical techniques using monospecific rabbit antibody to the 205,000-mol wt glycoprotein that is the C3b receptor of human peripheral blood cells. Anti-C3b receptor bound exclusively to podocytes in normal renal cortex, and was homogeneously distributed on the plasma membrane of these cells. Biosynthesis of the receptor by the podocyte was suggested by the presence of antigenic activity in the Golgi apparatus. Although occupancy of receptor sites following the interaction of kidney sections with aggregated IgG preincubated with normal serum inhibited binding to glomeruli of C3b coated cells, the C3b receptor remained accessible to anti-C3b receptor antibody. No staining of podocytes was found in extra-capillary proliferating cells in rapidly progressive glomerulonephritis (GN). Segmental loss of staining was found in focal hyalinosis, nodular diabetic glomerulosclerosis, and amyloidosis while no detectable C3b receptor antigen was found in severe proliferative nephritis of systemic lupus erythematosus (SLE). Normal staining of podocytes was found in other nephropathies with endocapillary proliferation such as acute GN and mesangial GN and in renal diseases associated with immune deposits containing C3 such as mesangial proliferative and membranous SLE nephritis, idiopathic membranous GN, membranoproliferative GN types I and II, mesangial GN with IgA or C3 deposition and Henoch Schönlein's purpura. Loss of C3b receptor antigen in the diffuse proliferative nephritis of SLE distinguishes it both from nonproliferative lupus nephritis and other immunologically mediated proliferative GN.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042757      PMCID: PMC370144          DOI: 10.1172/jci110529

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Analysis of glomerular complement receptors in various types of glomerulonephritis.

Authors:  A T Sobel; Y E Gabay; G Lagrue
Journal:  Clin Immunol Immunopathol       Date:  1976-07

2.  Editorial: Focal glomerular sclerosis.

Authors:  R Habib
Journal:  Kidney Int       Date:  1973-12       Impact factor: 10.612

3.  Structure and development of the glomerular crescent.

Authors:  T Morita; Y Suzuki; J Churg
Journal:  Am J Pathol       Date:  1973-09       Impact factor: 4.307

4.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

5.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

6.  Focal glomerular sclerosis in nephrotic patients: an electron microscopic study of glomerular podocytes.

Authors:  E Grishman; J Churg
Journal:  Kidney Int       Date:  1975-02       Impact factor: 10.612

7.  The macrophagen in human rapidly progressive glomerulonephritis.

Authors:  R C Atkins; S R Holdsworth; E F Glasgow; F E Matthews
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

8.  The glomerular complement receptor in immunologically mediated renal glomerular injury.

Authors:  M C Gelfand; M L Shin; R B Nagle; I Green; M M Frank
Journal:  N Engl J Med       Date:  1976-07-01       Impact factor: 91.245

9.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  A receptor for the third component of complement in the human renal glomerulus.

Authors:  M C Gelfand; M M Frank; I Green
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  49 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 2.  Ectosomes as immunomodulators.

Authors:  Salima Sadallah; Ceylan Eken; Jürg A Schifferli
Journal:  Semin Immunopathol       Date:  2010-12-07       Impact factor: 9.623

Review 3.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

Review 4.  What has the immune system got against the glomerular podocyte?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

5.  Immunohistochemical demonstration of parietal epithelial cells and macrophages in human proliferative extra-capillary lesions.

Authors:  C Guettier; D Nochy; C Jacquot; C Mandet; J P Camilleri; J Bariety
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.

Authors:  J G Wilson; R M Jack; W W Wong; P H Schur; D T Fearon
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Complement C3 gene expression and regulation in human glomerular epithelial cells.

Authors:  S H Sacks; W Zhou; A Pani; R D Campbell; J Martin
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

8.  Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.

Authors:  M Endoh; M Yamashina; H Ohi; K Funahashi; T Ikuno; T Yasugi; J P Atkinson; H Okada
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 9.  Minimal change nephropathy and focal segmental glomerulosclerosis.

Authors:  Peter W Mathieson
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

10.  ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry.

Authors:  Xana Kim-Howard; Amit K Maiti; Juan-Manuel Anaya; Gail R Bruner; Elizabeth Brown; Joan T Merrill; Jeffrey C Edberg; Michelle A Petri; John D Reveille; Rosalind Ramsey-Goldman; Graciela S Alarcon; Timothy J Vyse; Gary Gilkeson; Robert P Kimberly; Judith A James; Joel M Guthridge; John B Harley; Swapan K Nath
Journal:  Ann Rheum Dis       Date:  2009-11-25       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.